Keyword: respiratory diseases
News
18.03.2016
- UK drug maker Vectura is buying fellow biotechnology firm Skyepharma in a deal worth around £441 million ($637 million). The merger will create an industry leading specialist in...
News
06.11.2015
- GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...
